Infarto agudo del miocardio en hospitales chilenos: resultados finales del estudio GEMI / Acute myocardial infarction in chilean hospitals: results of the GEMI study
Prieto Domínguez, Juan Carlos; Corbalán H., Ramón; Chávez S., Eduardo; Lanas Zanetti, Fernando; Cumsille Garib, Francisco; Nazzal N., Carolina.
Rev. méd. Chile
; 127(7): 763-74, jul. 1999. tab, graf
Artículo
en Español
| LILACS | ID: lil-245381
Background:
Acute myocardial infarction is the leading cause of death in Chile.Aim:
To report the main features, hospital evolution, complications and pharmacological treatment of patients admitted to Chilean hospitals with the diagnosis of acute myocardial infarction. Patients andmethods:
Between 1993 and 1995, the GEMI group registered 2,957 patients admitted to 37 hospitals with the diagnosis of acute myocardial infarction.Results:
Mean age of patients was 62 ñ 2 years old and 74 percent were male. Forty six percent had a history of hypertension and 40 percent were smokers. During the first five days of admission, 93 percent of patients received aspirin, 59 percent received intravenous nitrates, 59 percent intravenous heparin, 56 percent oral nitrates, 37 percent beta blockers, 32 percent angiotensin-converting enzyme inhibitors, 33 percent thrombolytic agents, 29 percent antiarrhythmics and 23 percent calcium antagonists. Coronary angiograms were performed in 28 percent of patients, angioplasty in 9 percent and 8 percent were subjected to a coronary bypass. Global hospital mortality was 13.4 percent (19.5 percent in women and 11.1 percent in men, p <0.001).Conclusions:
This work gives a picture of myocardial infarction in Chilean hospitals. Pharmacological treatment is similar to that used abroad, but certainly it can be optimized
Biblioteca responsable:
CL1.1
Documentos relacionados